ABIVAX Société Anonyme's latest marketcap:
As of 06/13/2026, ABIVAX Société Anonyme's market capitalization has reached $7.85 B. According to our data, ABIVAX Société Anonyme is the 2731th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 7.85 B |
| Revenue (ttm) | 5.67 M |
| Net Income (ttm) | -383,027,787 |
| Shares Out | 79.29 M |
| EPS (ttm) | -5.22 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 03/23/2026 |
ABIVAX Société Anonyme's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/13/2026 | $7.85 B | -29.62% | 2731 |
| 12/31/2025 | $11 B | 2382.1% | 14604 |
| 12/31/2024 | $443.27 M | -34.81% | 13756 |
| 12/29/2023 | $679.99 M | 513.79% | 10957 |
| 12/30/2022 | $110.78 M | -79.15% | 21618 |
| 12/31/2021 | $531.29 M | -8.73% | 12956 |
| 12/31/2020 | $582.13 M | 95.59% | 10794 |
| 12/31/2019 | $297.64 M | 119.98% | n/a |
| 12/31/2018 | $135.3 M | 34.49% | n/a |
| 12/29/2017 | $100.6 M | 56.75% | n/a |
Company Profile
About ABIVAX Société Anonyme
ABIVAX Société Anonyme is a clinical-stage biotechnology company dedicated to developing innovative therapeutics that leverage the body's natural regulatory mechanisms to stabilize immune responses in patients with chronic inflammatory diseases.
Key Focus Areas
- Lead Drug Candidate: Obefazimod, currently in Phase 3 clinical trials for moderately to severely active ulcerative colitis in adults.
- Additional Research: Phase 2b clinical trial of obefazimod for Crohn’s disease.
Company Background
Founded in 2013, ABIVAX Société Anonyme is headquartered in Paris, France, and continues to advance its pipeline of immune-modulating therapies.
Frequently Asked Questions
-
What is ABIVAX Société Anonyme's (ABVX) current market cap?As of 06/13/2026, ABIVAX Société Anonyme (including the parent company, if applicable) has an estimated market capitalization of $7.85 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ABIVAX Société Anonyme (ABVX) rank globally by market cap?ABIVAX Société Anonyme global market capitalization ranking is approximately 2731 as of 06/13/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.